Regeneron Pharmaceuticals (REGN) Assets Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.85% |
| Dec 31, 2025 | 7.41% |
| Sep 30, 2025 | 7.28% |
| Jun 30, 2025 | 5.91% |
| Mar 31, 2025 | 9.24% |
| Dec 31, 2024 | 14.15% |
| Sep 30, 2024 | 16.41% |
| Jun 30, 2024 | 17.71% |
| Mar 31, 2024 | 14.34% |
| Dec 31, 2023 | 13.23% |
| Sep 30, 2023 | 16.21% |
| Jun 30, 2023 | 12.69% |
| Mar 31, 2023 | 14.08% |
| Dec 31, 2022 | 14.86% |
| Sep 30, 2022 | 16.92% |
| Jun 30, 2022 | 26.62% |
| Mar 31, 2022 | 48.26% |
| Dec 31, 2021 | 48.19% |
| Sep 30, 2021 | 47.17% |
| Jun 30, 2021 | 48.91% |
| Mar 31, 2021 | 12.79% |
| Dec 31, 2020 | 15.93% |
| Sep 30, 2020 | 15.39% |
| Jun 30, 2020 | 9.53% |
| Mar 31, 2020 | 22.58% |
| Dec 31, 2019 | 26.17% |
| Sep 30, 2019 | 29.00% |
| Jun 30, 2019 | 32.37% |
| Mar 31, 2019 | 37.15% |
| Dec 31, 2018 | 33.89% |
| Sep 30, 2018 | 24.19% |
| Jun 30, 2018 | 22.77% |
| Mar 31, 2018 | 19.90% |
| Dec 31, 2017 | 25.68% |
| Sep 30, 2017 | 27.43% |
| Jun 30, 2017 | 30.64% |
| Mar 31, 2017 | 32.40% |
| Dec 31, 2016 | 24.32% |
| Sep 30, 2016 | 31.74% |
| Jun 30, 2016 | 37.07% |
| Mar 31, 2016 | 40.63% |
| Dec 31, 2015 | 46.16% |
| Sep 30, 2015 | 38.60% |
| Jun 30, 2015 | 30.99% |
| Mar 31, 2015 | 28.77% |
| Dec 31, 2014 | 30.05% |
| Sep 30, 2014 | 41.62% |
| Jun 30, 2014 | 45.32% |
| Mar 31, 2014 | 43.25% |
| Dec 31, 2013 | 41.84% |
| Sep 30, 2013 | 59.00% |
| Jun 30, 2013 | 63.17% |
| Mar 31, 2013 | 68.57% |
| Dec 31, 2012 | 57.19% |
| Sep 30, 2012 | 68.93% |
| Jun 30, 2012 | 39.23% |
| Mar 31, 2012 | 25.68% |
| Dec 31, 2011 | 21.49% |
| Sep 30, 2011 | 4.31% |
| Jun 30, 2011 | 32.41% |
| Dec 31, 2010 | 46.98% |